Bank of New York Mellon’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-201,828
| Closed | -$63.9M | – | 4350 |
|
|
2023
Q4 | $63.9M | Sell |
201,828
-8,237
| -4% | -$2.61M | 0.01% | 892 |
|
|
2023
Q3 | $35.5M | Buy |
210,065
+7,464
| +4% | +$1.26M | 0.01% | 1197 |
|
|
2023
Q2 | $43.9M | Sell |
202,601
-17,301
| -8% | -$3.75M | 0.01% | 1096 |
|
|
2023
Q1 | $39.9M | Buy |
219,902
+3,504
| +2% | +$636K | 0.01% | 1148 |
|
|
2022
Q4 | $42.5M | Sell |
216,398
-2,404
| -1% | -$472K | 0.01% | 1099 |
|
|
2022
Q3 | $49.2M | Sell |
218,802
-45,537
| -17% | -$10.2M | 0.01% | 967 |
|
|
2022
Q2 | $33.4M | Buy |
264,339
+52,661
| +25% | +$6.66M | 0.01% | 1224 |
|
|
2022
Q1 | $26.8M | Buy |
211,678
+120,709
| +133% | +$15.3M | 0.01% | 1484 |
|
|
2021
Q4 | $11.9M | Buy |
90,969
+1,530
| +2% | +$200K | ﹤0.01% | 2007 |
|
|
2021
Q3 | $10.9M | Buy |
89,439
+8,122
| +10% | +$994K | ﹤0.01% | 2067 |
|
|
2021
Q2 | $9.27M | Buy |
81,317
+20,239
| +33% | +$2.31M | ﹤0.01% | 2182 |
|
|
2021
Q1 | $7.34M | Sell |
61,078
-3,791
| -6% | -$456K | ﹤0.01% | 2261 |
|
|
2020
Q4 | $6.59M | Sell |
64,869
-1,738
| -3% | -$177K | ﹤0.01% | 2229 |
|
|
2020
Q3 | $5.15M | Sell |
66,607
-5,198
| -7% | -$402K | ﹤0.01% | 2203 |
|
|
2020
Q2 | $8M | Buy |
71,805
+16,497
| +30% | +$1.84M | ﹤0.01% | 1963 |
|
|
2020
Q1 | $3.98M | Buy |
55,308
+15,508
| +39% | +$1.12M | ﹤0.01% | 2188 |
|
|
2019
Q4 | $3M | Buy |
39,800
+28,149
| +242% | +$2.12M | ﹤0.01% | 2594 |
|
|
2019
Q3 | $190K | Buy |
+11,651
| New | +$190K | ﹤0.01% | 3907 |
|